Hunter Fasanaro’s Post

🌟 𝐄𝐧𝐡𝐚𝐧𝐜𝐢𝐧𝐠 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐀𝐥𝐥𝐢𝐚𝐧𝐜𝐞𝐬 𝐟𝐨𝐫 𝐁𝐞𝐭𝐭𝐞𝐫 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐎𝐮𝐭𝐜𝐨𝐦𝐞𝐬🌟 At Archo Advocacy, LLC, we recognize that one of the critical challenges in #healthcare advocacy is inconsistent stakeholder engagement. Many healthcare organizations struggle with developing clear and effective strategies for engaging with patient advocacy organizations and professional societies. This often leads to missed opportunities for partnerships that could significantly enhance patient outcomes. Understanding what advocacy organizations and professional societies truly need is key to overcoming this challenge. By gaining deeper insights into these needs, healthcare companies can create or strengthen strategic alliances that are not only mutually beneficial but also centered on making a real difference in patients’ lives. We are committed to guiding and supporting healthcare organizations in this journey. By fostering focused and strategic partnerships, we aim to ensure that every alliance is poised to improve patient care and advocacy efforts significantly. Together, we can build a future where strategic alliances lead to meaningful changes in the lives of those we serve. #HealthcareAdvocacy #PatientOutcomes #StrategicAlliances #PatientCare #HealthcareInnovation

Our latest blog post discusses The Importance of Patient Advocacy in Healthcare Patient advocacy plays a crucial role in ensuring that individuals receive the best possible care and have their voices heard within the complex healthcare system. As healthcare becomes increasingly complex, the role of patient advocates has become more important than ever. https://loom.ly/iN33D6Q

🍎 💭 𝐅𝐨𝐨𝐝 𝐟𝐨𝐫 𝐓𝐡𝐨𝐮𝐠𝐡𝐭: The gap between knowledge & execution in patient advocacy can be significant. Many #advocacy teams struggle to align their efforts with the most effective strategies due to a lack of actionable data. Often, teams rely on internal metrics that may reflect positively on their efforts but fail to provide a true measure of impact. Conversely, some measure patient & community initiatives without a clear understanding of their internal resources, budget, or how these align with industry standards. Effective advocacy requires both proactive & reactive approaches to accurately gauge effectiveness. The need for comprehensive tools in #healthcare advocacy is critical. Imagine your team empowered with actionable insights that meet real patient needs, leading with confidence and backed by data that validates and advances your role. Isn't it time we bridged these gaps?

𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐚𝐝𝐯𝐨𝐜𝐚𝐜𝐲 𝐭𝐞𝐚𝐦𝐬 𝐚𝐫𝐞 𝐟𝐢𝐠𝐡𝐭𝐢𝐧𝐠 𝐚𝐧 𝐮𝐩𝐡𝐢𝐥𝐥 𝐛𝐚𝐭𝐭𝐥𝐞— shrinking budgets, smaller teams, and the challenge of proving their impact without direct ties to commercial success. 𝘠𝘦𝘵, 𝘢𝘥𝘷𝘰𝘤𝘢𝘤𝘺 𝘪𝘴 𝘢 𝘭𝘰𝘯𝘨-𝘵𝘦𝘳𝘮 𝘴𝘵𝘳𝘢𝘵𝘦𝘨𝘺 𝘵𝘩𝘢𝘵 𝘥𝘰𝘦𝘴𝘯’𝘵 𝘧𝘪𝘵 𝘯𝘦𝘢𝘵𝘭𝘺 𝘪𝘯𝘵𝘰 𝘲𝘶𝘢𝘳𝘵𝘦𝘳𝘭𝘺 𝘰𝘳 𝘢𝘯𝘯𝘶𝘢𝘭 𝘣𝘶𝘥𝘨𝘦𝘵𝘴. 🔴 Senior leadership needs to understand that advocacy is about more than just short-term ROI and cant be treated like just another line item on a budget. Advocacy teams need to be empowered—both internally and externally—with the insights to clearly demonstrate their value, justify engagement strategies, and prioritize resources where they can have the greatest impact. 𝐇𝐨𝐰 𝐝𝐨 𝐰𝐞 𝐬𝐡𝐢𝐟𝐭 𝐭𝐡𝐞 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧 𝐭𝐨 𝐞𝐧𝐬𝐮𝐫𝐞 𝐚𝐝𝐯𝐨𝐜𝐚𝐜𝐲 𝐢𝐬 𝐬𝐞𝐞𝐧 𝐚𝐬 𝐚 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜, 𝐥𝐨𝐧𝐠-𝐭𝐞𝐫𝐦 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭? #PatientAdvocacy #HealthcareLeaders #Pharma #PatientCentricCare #PatientOutcomes #CommunityEngagement #PatientExperience #PublicHealth

Don't miss our latest take on partnering with patient advocacy groups in clinical research! It’s packed with practical tips for study sponsors to boost patient engagement and drive trial success. 👉 https://lnkd.in/gqBwQ9RB #PatientWing #PatientRecruitment #ClinicalResearch #PatientAdvocacy

You can't cross these drug development milestones without mapping out the key patient advocacy stakeholders that you could involve. Check out what these milestones are 👇 🟣 Stay tuned for a complete step-by-step walkthrough in our upcoming blog post on how to develop a meaningful and comprehensive patient advocacy group landscape.

💬 Last week, our community highlighted the essential role of patient advocacy in comms, with many of us integrating it as a core element of our overarching strategy. Discussions showed the need for regular engagement with patient advocacy organizations and ensuring patient voices are included in the comms development process. Key takeaway: Effective patient advocacy communication hinges on routine involvement and cross-department collaboration to ensure messages are consistently supportive and patient-focused.

Is your #patientadvocacy organization shaping regulatory decisions with real-world evidence (RWE)? In this blog, #IQVIA’s Angela Nicholas and Reid D'Amico, Ph.D. explore how patient advocacy organizations can use RWE to drive change within their #patientcommunities. Learn more here: https://bit.ly/406mYeJ

Understanding who your primary stakeholders are is a vital first step for effective market access strategies. Our Head of Policy & Public Affairs Nisha Tailor takes a look at who they are and explores some best practices for engaging with them.   Dive into our carousel to learn about engaging with HTA bodies, patient advocacy groups and more.   #stakeholderengagement #marketaccess #blog

Discover how Patient Advocacy Groups (PAGs) are revolutionizing #RareDisease research and driving clinical and commercial success. Read our latest blog to learn how IQVIA is partnering with PAGs to advance innovative treatments and improve patient outcomes. Read now: https://bit.ly/3ZDKttA